The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
